Loading...
Allogeneic CAR Cell Therapy—More Than a Pipe Dream
Adoptive cellular immunotherapy using immune cells expressing chimeric antigen receptors (CARs) has shown promise, particularly for the treatment of hematological malignancies. To date, the majority of clinically evaluated CAR cell products have been derived from autologous immune cells. While this...
Saved in:
| Published in: | Front Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7821739/ https://ncbi.nlm.nih.gov/pubmed/33488631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.618427 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|